Targeting CXCR2 to suppress the migration and invasion of ESCC cells by inhibiting the function of not only CXCL8 but also other C-X-C motif chemokines derived from TAMs may be a rather effective therapy for ESCC. The gene discussed is CXCL8; the disease is esophageal squamous cell carcinoma.